TCRX
USDTScan Therapeutics Inc. Common Stock
$1.120-0.050 (-4.274%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$1.170
고가
$1.250
저가
$1.080
거래량
0.81M
기업 기본 정보
시가총액
63.6M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.51M
거래소
NGM
통화
USD
52주 범위
저가 $1.02현재가 $1.120고가 $6.225
관련 뉴스
Analyst Upgrades
BTIG Downgrades TScan Therapeutics to Neutral
BTIG analyst Justin Zelin downgrades TScan Therapeutics from Buy to Neutral.
더 보기
Analyst Upgrades
Needham Maintains Buy on TScan Therapeutics, Lowers Price Target to $6
Needham analyst Gil Blum maintains TScan Therapeutics with a Buy and lowers the price target from $9 to $6.
더 보기
GlobeNewswire
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to prioritize heme development;
더 보기
